BEATTUMOR
Jinfiniti Precision Medicine, Inc.
Mark For: BEATTUMOR® trademark registration is intended to cover the categories of
| Research |
OneLook
Acronym Finder
|
| Serial Number | 88479156 |
| Registration Number | 6727023 |
| Mark Literal Elements | BEATTUMOR |
| Mark Drawing Type | 4 - STANDARD CHARACTER MARK |
| Mark Type | SERVICE MARK |
| Register | PRINCIPAL |
| Current Location | TMO LAW OFFICE 122 - EXAMINING ATTORNEY ASSIGNED 2019-09-26 |
| Basis | 1(a) |
| Class Status | ACTIVE |
| Primary US Classes |
|
| Primary International Class |
|
| Filed Use | Yes |
| Current Use | Yes |
| Intent To Use | No |
| Filed ITU | No |
| 44D Filed | No |
| 44E Current | No |
| 66A Current | No |
| Current Basis | No |
| No Basis | No |
| Attorney Name | Bernard H. Coleman, Esq. |
| Law Office Assigned | N40 |
| Employee Name | WINTER, MELISSA S |
Timeline
| 2019-01-01 | Date of First Use |
| 2019-04-01 | Date of Use In Commerce |
| 2019-06-19 | Application Filed |
| 2019-09-26 | Location: TMO LAW OFFICE 122 - EXAMINING ATTORNEY ASSIGNED |
| 2019-09-26 | Status: Live/Pending |
| 2019-09-26 | Transaction Date |
| 2020-03-26 | Status: Applicant's response to a non-final Office action has been entered. The application is being returned to the examining attorney |
| 2022-05-24 | Trademark Registered |
Trademark Parties (Applicants & Owners)
| Party: |  Jinfiniti Precision Medicine, Inc. |
| Address | 1120 15th St, Rm CA2132A Augusta, GEORGIA UNITED STATES 30912 |
| Legal Entity Type | Corporation |
| Legal Entity State | GEORGIA |
Documents
 Drawing | JPEG | 2019-06-19 |
| Specimen | JPEG | 2019-06-19 |
 TEAS RF New Application | MULTI | 2019-06-19 |
| XSearch Search Summary | XML | 2019-09-16 |
| Offc Action Outgoing | MULTI | 2019-09-26 |
| Response to Office Action | MULTI | 2020-03-26 |
| Amendment and Mail Process Complete | APPLICATION/XML,IMAGE/JPEG | 2020-03-27 |
Attorney of Record
Good, Services, and Codes
IC 044. US 100 101. G & S: medical analysis services for treatment purposes provided by medical laboratories, namely, biofunctional evaluation of anticancer therapies; medical analysis services for treatment purposes provided by medical laboratories, namely, cancer drug sensitivity testing for treatment selection and personalized medicine. FIRST USE: 20190101. FIRST USE IN COMMERCE: 20190401
| International Codes: | 44 |
| U.S. Codes: | 100,101 |
| Type Code | Type |
|---|---|
| GS0441 | Biofunctional evaluation of anticancer therapies, cancer drug sensitivity testing for treatment selection and personalized medicine |
| PM0002 | BIOFUNCTIONAL EVALUATION OF ANTICANCER THERAPIES TUMOR |
Trademark Filing History
| Description | Date | Proceeding Number |
|---|---|---|
| TEAS/EMAIL CORRESPONDENCE ENTERED | 2020-03-26 | 88889 |
| TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2020-03-26 | |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2020-03-26 | 88889 |
| NOTIFICATION OF NON-FINAL ACTION E-MAILED | 2019-09-26 | 6325 |
| NON-FINAL ACTION WRITTEN | 2019-09-26 | 93062 |
| NON-FINAL ACTION E-MAILED | 2019-09-26 | 6325 |
| ASSIGNED TO EXAMINER | 2019-09-10 | 93062 |
| NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2019-06-29 | |
| NEW APPLICATION ENTERED IN TRAM | 2019-06-22 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 